Trial Profile
Phase I renal clearance study of ELND 005 in subjects with renal impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2015
Price :
$35
*
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 28 Mar 2015 New trial record
- 26 Mar 2015 Results published in the Media Release.